Showing 9,161 - 9,180 results of 49,729 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (mean decrease)) ))', query time: 1.01s Refine Results
  1. 9161
  2. 9162
  3. 9163

    Final dataset. by Keiko Ochiai (21453423)

    Published 2025
    Subjects:
  4. 9164
  5. 9165
  6. 9166
  7. 9167
  8. 9168

    Age at treatment initiation–cross sex hormones. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  9. 9169

    Study characteristics. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  10. 9170

    Age at treatment initiation–puberty suppression. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  11. 9171

    Search terms. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  12. 9172

    PRISMA diagram. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  13. 9173

    PRISMA 2020 checklist. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  14. 9174

    Flow diagram of the study population. by Dina Evyana (18462048)

    Published 2024
    “…MetS was found in 64.3% of patients. Patients with a PASI score>10 had a significantly higher risk of metabolic syndrome compared to those with a score ≤ 10 (78.6% vs 50%, OR 3.667; 95% CI 1.413–9.514; <i>p</i> = 0.006). …”
  15. 9175
  16. 9176

    Input Filter 5–10Hz. by Elías M. Fernández Santoro (22470299)

    Published 2025
    “…For the 5–10 Hz filter in the Upbound zone, STO frequency seems to decrease while STO spikes increase. …”
  17. 9177

    IDD388 Polyhalogenated Derivatives as Probes for an Improved Structure-Based Selectivity of AKR1B10 Inhibitors by Alexandra Cousido-Siah (777034)

    Published 2016
    “…Next, by means of IC<sub>50</sub> measurements, X-ray crystallography, WaterMap analysis, and advanced binding free energy calculations with a quantum-mechanical (QM) approach, we have studied their structure–activity relationship (SAR) against both enzymes. …”
  18. 9178
  19. 9179
  20. 9180